课题基金 / 基金详情

The development of multi-functional enzyme-based therapy against Triple Negative Breast Cancer

The development of multi-functional enzyme-based therapy against Triple Negative Breast Cancer
针对三阴性乳腺癌的多功能酶疗法的开发
批准号:
22KJ1057
负责人:
黄 薇恩
金额:
$1.6万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for JSPS Fellows
财政年份:
2023
资助国家:
日本
项目状态:
未结题
起止时间:
2023-03-08 至 2025-03-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Firstly, I wanted to identify the macrocyclic peptides against Colony-Stimulating Factor-1 Receptor expressed on the macrophage. The activation from macrophage colony stimulating factor emitted form cancer cell would induce the polarization of immunostimulatory macrophage to immunosuppressive Tumor-Associated Macrophage. The RaPID mRNA display was applied to discover the peptides binder to biotinylated MCSF immobilized on streptavidin magnetic beads. The selection was conducted for five consecutive rounds including the positive rounds with MCSF immobilized beads and negative rounds with empty biotin masked streptavidin magnetic beads. Based on the next generation sequencing results, the majority of acquired binders results did not show difference between positive and negative rounds.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
TAM 重塑协同 ICD 诱导的黄芪-莪术组分复合水凝胶构建及其助 TNBC“寒转热”增效免疫治疗的机制研究
  • 批准号:
    ZCLMS26H2801
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    张婷
  • 依托单位:
PGLYRP1缺失介导线粒体转移驱动肿瘤相关巨噬细胞(TAM)M2型极化促进口腔癌转移及免疫逃逸的机制研究
  • 批准号:
    2026JJ82142
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    王薇王
  • 依托单位:
β1-integrin介导的Warburg效应在TAM耐药乳腺癌中的作用及机制
  • 批准号:
    JCZRLH202600554
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
低氧肿瘤微环境通过调控 FOXO3a 亚细胞定位介导 TAM 依赖性 PD-L1 表达在肝细胞肝癌免疫治疗耐药中的作用及机制研究
  • 批准号:
    ZCLQN26H1606
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    董哲斌
  • 依托单位: